Cellectis (CLLS) Receivables - Other (2014 - 2026)
Cellectis' (CLLS) quarterly Receivables - Other came in at $7.6 million in Q1 2026, down 49.77% year-on-year from $15.1 million in Q1 2025, and down 2.64% quarter-over-quarter from $7.8 million in Q4 2025.
Cellectis (CLLS) Receivables - Other (2014 - 2026) Analysis & Trends
Cellectis' Receivables - Other history runs 13 years deep, the most recent figure standing at $7.6 million for Q1 2026.
- On a quarterly basis, Receivables - Other fell 49.77% year-over-year to $7.6 million in Q1 2026; TTM through Mar 2026 was $7.6 million, a 49.77% decrease from a year earlier, with the FY2025 full-year figure at $7.8 million, down 46.28% from the prior year.
- Receivables - Other fell to $7.6 million in Q1 2026 per CLLS's latest filing, from $7.8 million in the prior quarter.
- Across five years, Receivables - Other topped out at $23.1 million in Q1 2024 and bottomed at $7.6 million in Q1 2026.
- The 5-year median for Receivables - Other is $15.1 million (2025), against an average of $15.2 million.
- Across the five-year window, Receivables - Other jumped 98.87% in 2022 and plunged 49.77% in 2026, its largest moves.
- Year by year, Receivables - Other stood at $14.5 million in 2022, then surged by 44.18% to $20.9 million in 2023, then slumped by 30.52% to $14.5 million in 2024, then sank by 46.28% to $7.8 million in 2025, then dropped by 2.64% to $7.6 million in 2026.
- Per Business Quant, the three latest CLLS Receivables - Other figures stand at $7.6 million (Q1 2026), $7.8 million (Q4 2025), and $16.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.59 Mn |
| Mar 31, 2026 | 7.59 Mn |
| Dec 31, 2025 | 7.80 Mn |
| Dec 31, 2025 | 7.80 Mn |
| Sep 30, 2025 | 16.41 Mn |
| Sep 30, 2025 | 16.41 Mn |
| Jun 30, 2025 | 16.38 Mn |
| Jun 30, 2025 | 16.38 Mn |
| Mar 31, 2025 | 15.12 Mn |
| Mar 31, 2025 | 15.12 Mn |
| Dec 31, 2024 | 14.52 Mn |
| Dec 31, 2024 | 14.52 Mn |
| Sep 30, 2024 | 15.66 Mn |
| Sep 30, 2024 | 15.66 Mn |
| Jun 30, 2024 | 14.96 Mn |
| Jun 30, 2024 | 14.96 Mn |
| Mar 31, 2024 | 23.10 Mn |
| Mar 31, 2024 | 23.10 Mn |
| Dec 31, 2023 | 20.90 Mn |
| Dec 31, 2023 | 20.90 Mn |